Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Colorectal Neoplasms | 17 | 2022 | 6773 | 1.040 |
Why?
|
Colonic Neoplasms | 9 | 2021 | 2542 | 0.910 |
Why?
|
DNA Glycosylases | 2 | 2022 | 128 | 0.880 |
Why?
|
Esophageal Neoplasms | 4 | 2023 | 1585 | 0.740 |
Why?
|
Adenoma | 6 | 2020 | 2174 | 0.540 |
Why?
|
Aspirin | 4 | 2022 | 3283 | 0.450 |
Why?
|
Adenomatous Polyps | 1 | 2014 | 107 | 0.440 |
Why?
|
Adenocarcinoma | 3 | 2023 | 6364 | 0.380 |
Why?
|
Endometrial Neoplasms | 1 | 2020 | 1351 | 0.370 |
Why?
|
Receptors, CXCR4 | 1 | 2015 | 727 | 0.360 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2020 | 2282 | 0.340 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2011 | 241 | 0.330 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2015 | 2043 | 0.310 |
Why?
|
Genetic Predisposition to Disease | 12 | 2023 | 17446 | 0.310 |
Why?
|
Barrett Esophagus | 2 | 2023 | 494 | 0.300 |
Why?
|
Precancerous Conditions | 1 | 2014 | 975 | 0.290 |
Why?
|
Genome-Wide Association Study | 12 | 2022 | 12262 | 0.280 |
Why?
|
Germ-Line Mutation | 1 | 2014 | 1788 | 0.270 |
Why?
|
Microsatellite Instability | 2 | 2020 | 684 | 0.240 |
Why?
|
ras Proteins | 3 | 2014 | 1060 | 0.230 |
Why?
|
Molecular Targeted Therapy | 1 | 2014 | 2725 | 0.220 |
Why?
|
Peptides | 1 | 2015 | 4410 | 0.220 |
Why?
|
Sulindac | 1 | 2002 | 29 | 0.210 |
Why?
|
Genomics | 4 | 2022 | 5717 | 0.210 |
Why?
|
Adenomatous Polyposis Coli | 2 | 2014 | 224 | 0.190 |
Why?
|
Carcinoma, Verrucous | 1 | 2020 | 23 | 0.190 |
Why?
|
Rectal Neoplasms | 2 | 2021 | 1205 | 0.190 |
Why?
|
Antineoplastic Agents | 2 | 2020 | 13693 | 0.180 |
Why?
|
Microsatellite Repeats | 2 | 2020 | 802 | 0.180 |
Why?
|
Interferon Regulatory Factor-3 | 1 | 2020 | 123 | 0.170 |
Why?
|
DNA Polymerase II | 1 | 2020 | 107 | 0.170 |
Why?
|
Genetic Variation | 4 | 2020 | 6542 | 0.170 |
Why?
|
Polymorphism, Single Nucleotide | 10 | 2021 | 15520 | 0.160 |
Why?
|
Gap Junctions | 1 | 2020 | 233 | 0.160 |
Why?
|
Polyps | 1 | 2020 | 189 | 0.160 |
Why?
|
Nucleotidyltransferases | 1 | 2020 | 220 | 0.160 |
Why?
|
Liver Diseases, Alcoholic | 1 | 2020 | 161 | 0.160 |
Why?
|
Genetic Loci | 2 | 2019 | 2575 | 0.160 |
Why?
|
Dinoprostone | 1 | 2020 | 601 | 0.150 |
Why?
|
Genetic Heterogeneity | 1 | 2021 | 733 | 0.150 |
Why?
|
DNA Mismatch Repair | 1 | 2020 | 426 | 0.140 |
Why?
|
Proto-Oncogene Proteins | 3 | 2014 | 4554 | 0.140 |
Why?
|
Drug Tolerance | 1 | 2018 | 376 | 0.140 |
Why?
|
Colon | 2 | 2021 | 1772 | 0.130 |
Why?
|
Anticarcinogenic Agents | 1 | 2017 | 253 | 0.130 |
Why?
|
BRCA2 Protein | 1 | 2020 | 794 | 0.130 |
Why?
|
Retinoblastoma-Like Protein p107 | 1 | 2014 | 74 | 0.120 |
Why?
|
Adrenomedullin | 1 | 2013 | 87 | 0.120 |
Why?
|
Crohn Disease | 2 | 2018 | 2304 | 0.120 |
Why?
|
Common Bile Duct Neoplasms | 1 | 2014 | 111 | 0.120 |
Why?
|
Ampulla of Vater | 1 | 2014 | 141 | 0.110 |
Why?
|
Gallstones | 1 | 2016 | 286 | 0.110 |
Why?
|
Case-Control Studies | 8 | 2021 | 21748 | 0.110 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2020 | 1222 | 0.110 |
Why?
|
DNA Helicases | 2 | 2020 | 861 | 0.110 |
Why?
|
BRCA1 Protein | 1 | 2020 | 1149 | 0.110 |
Why?
|
Gastrointestinal Agents | 1 | 2018 | 494 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2014 | 318 | 0.110 |
Why?
|
Strongyloides stercoralis | 1 | 2012 | 23 | 0.110 |
Why?
|
Codon, Nonsense | 1 | 2014 | 281 | 0.110 |
Why?
|
Strongyloidiasis | 1 | 2012 | 27 | 0.110 |
Why?
|
Humans | 38 | 2023 | 744366 | 0.100 |
Why?
|
HTLV-I Infections | 1 | 2012 | 101 | 0.100 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 3 | 2014 | 1692 | 0.100 |
Why?
|
Bone Morphogenetic Protein 4 | 1 | 2012 | 162 | 0.100 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2002 | 2943 | 0.100 |
Why?
|
Peutz-Jeghers Syndrome | 1 | 2011 | 50 | 0.100 |
Why?
|
Prospective Studies | 7 | 2022 | 53290 | 0.100 |
Why?
|
Endoscopy, Digestive System | 1 | 2014 | 345 | 0.100 |
Why?
|
DNA Mutational Analysis | 1 | 2020 | 4185 | 0.100 |
Why?
|
Telomere | 1 | 2016 | 910 | 0.090 |
Why?
|
Male | 21 | 2023 | 350115 | 0.090 |
Why?
|
Jejunum | 1 | 2012 | 480 | 0.090 |
Why?
|
Aged | 15 | 2022 | 163288 | 0.090 |
Why?
|
DNA Repair | 1 | 2019 | 2046 | 0.090 |
Why?
|
Oncogene Proteins | 1 | 2014 | 749 | 0.090 |
Why?
|
Neoplasms | 2 | 2016 | 21696 | 0.080 |
Why?
|
Medical Informatics | 1 | 2016 | 745 | 0.080 |
Why?
|
Intracellular Signaling Peptides and Proteins | 3 | 2018 | 2916 | 0.080 |
Why?
|
Disease Progression | 4 | 2023 | 13286 | 0.080 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2023 | 11726 | 0.080 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2014 | 1157 | 0.080 |
Why?
|
Female | 20 | 2023 | 380193 | 0.080 |
Why?
|
Genetic Association Studies | 2 | 2016 | 2703 | 0.080 |
Why?
|
Anti-Inflammatory Agents | 1 | 2018 | 1790 | 0.080 |
Why?
|
Databases, Genetic | 1 | 2015 | 1783 | 0.080 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2020 | 8432 | 0.080 |
Why?
|
Models, Genetic | 1 | 2018 | 3493 | 0.080 |
Why?
|
Genotype | 5 | 2021 | 12952 | 0.080 |
Why?
|
Genetic Markers | 1 | 2014 | 2634 | 0.070 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2011 | 379 | 0.070 |
Why?
|
Natural Language Processing | 1 | 2015 | 1041 | 0.070 |
Why?
|
Middle Aged | 17 | 2022 | 213390 | 0.070 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2020 | 2988 | 0.070 |
Why?
|
Mutation | 2 | 2022 | 29786 | 0.070 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2018 | 4424 | 0.070 |
Why?
|
Software | 2 | 2018 | 4441 | 0.070 |
Why?
|
Carcinoma | 1 | 2017 | 2375 | 0.060 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2020 | 5172 | 0.060 |
Why?
|
Workflow | 2 | 2022 | 847 | 0.060 |
Why?
|
Odds Ratio | 4 | 2020 | 9849 | 0.060 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2014 | 1862 | 0.060 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2014 | 2917 | 0.060 |
Why?
|
Colitis, Ulcerative | 1 | 2015 | 1911 | 0.050 |
Why?
|
Adult | 12 | 2023 | 214052 | 0.050 |
Why?
|
Sequence Analysis, DNA | 1 | 2014 | 4805 | 0.050 |
Why?
|
Interleukin-8 | 1 | 2005 | 690 | 0.050 |
Why?
|
Genes, src | 1 | 2002 | 52 | 0.050 |
Why?
|
Septins | 1 | 2022 | 52 | 0.050 |
Why?
|
Aged, 80 and over | 7 | 2021 | 57776 | 0.050 |
Why?
|
Colon, Descending | 1 | 2021 | 8 | 0.050 |
Why?
|
Colon, Ascending | 1 | 2021 | 16 | 0.050 |
Why?
|
Neoplasm Proteins | 1 | 2014 | 3707 | 0.050 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2023 | 2949 | 0.050 |
Why?
|
Colon, Transverse | 1 | 2021 | 23 | 0.050 |
Why?
|
Risk Factors | 7 | 2023 | 72296 | 0.050 |
Why?
|
DNA-Binding Proteins | 2 | 2019 | 9647 | 0.050 |
Why?
|
Prostatic Neoplasms | 1 | 2023 | 11126 | 0.050 |
Why?
|
Colon, Sigmoid | 1 | 2021 | 120 | 0.050 |
Why?
|
Follow-Up Studies | 5 | 2020 | 39052 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2006 | 988 | 0.050 |
Why?
|
Cecum | 1 | 2021 | 237 | 0.050 |
Why?
|
3T3 Cells | 1 | 2002 | 1101 | 0.050 |
Why?
|
Biopsy | 2 | 2023 | 6755 | 0.040 |
Why?
|
Young Adult | 7 | 2021 | 56429 | 0.040 |
Why?
|
Hyperplasia | 1 | 2023 | 1185 | 0.040 |
Why?
|
Signal Transduction | 3 | 2020 | 23404 | 0.040 |
Why?
|
Genes, ras | 1 | 2002 | 690 | 0.040 |
Why?
|
Esophagoscopy | 1 | 2020 | 390 | 0.040 |
Why?
|
Risk Assessment | 4 | 2023 | 23336 | 0.040 |
Why?
|
DNA Modification Methylases | 1 | 2019 | 206 | 0.040 |
Why?
|
Numerical Analysis, Computer-Assisted | 1 | 2018 | 125 | 0.040 |
Why?
|
Delivery of Health Care | 1 | 2016 | 5321 | 0.040 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2006 | 3511 | 0.040 |
Why?
|
Alleles | 2 | 2021 | 6933 | 0.040 |
Why?
|
DNA Repair Enzymes | 1 | 2019 | 349 | 0.040 |
Why?
|
Early Detection of Cancer | 2 | 2022 | 3086 | 0.040 |
Why?
|
Genes, Neoplasm | 1 | 2018 | 376 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2006 | 2938 | 0.030 |
Why?
|
Prostaglandins | 1 | 2017 | 405 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2014 | 9240 | 0.030 |
Why?
|
Caco-2 Cells | 1 | 2016 | 387 | 0.030 |
Why?
|
HCT116 Cells | 1 | 2016 | 409 | 0.030 |
Why?
|
Hep G2 Cells | 1 | 2016 | 393 | 0.030 |
Why?
|
Neovascularization, Pathologic | 1 | 2005 | 2638 | 0.030 |
Why?
|
Computational Biology | 2 | 2018 | 3519 | 0.030 |
Why?
|
Age Distribution | 1 | 2021 | 2902 | 0.030 |
Why?
|
Animals | 6 | 2020 | 168768 | 0.030 |
Why?
|
Double-Blind Method | 2 | 2020 | 12025 | 0.030 |
Why?
|
Algorithms | 1 | 2015 | 13882 | 0.030 |
Why?
|
Rectum | 1 | 2019 | 904 | 0.030 |
Why?
|
Cell Division | 1 | 2002 | 4569 | 0.030 |
Why?
|
Age of Onset | 1 | 2021 | 3270 | 0.030 |
Why?
|
Tumor Microenvironment | 2 | 2018 | 3590 | 0.030 |
Why?
|
Kinetics | 1 | 2002 | 6476 | 0.030 |
Why?
|
Duodenal Neoplasms | 1 | 2014 | 106 | 0.030 |
Why?
|
Prognosis | 3 | 2020 | 29060 | 0.030 |
Why?
|
Transfection | 1 | 2002 | 5895 | 0.030 |
Why?
|
Mice, Nude | 2 | 2013 | 3689 | 0.030 |
Why?
|
Risk | 2 | 2016 | 9688 | 0.030 |
Why?
|
Transcription Factors | 2 | 2020 | 12207 | 0.030 |
Why?
|
Hepatocytes | 1 | 2020 | 1211 | 0.030 |
Why?
|
Remission Induction | 1 | 2018 | 2385 | 0.030 |
Why?
|
Registries | 2 | 2019 | 8091 | 0.030 |
Why?
|
Chromones | 1 | 2012 | 154 | 0.030 |
Why?
|
Human T-lymphotropic virus 1 | 1 | 2012 | 140 | 0.030 |
Why?
|
Linkage Disequilibrium | 1 | 2016 | 1997 | 0.020 |
Why?
|
Telomerase | 1 | 2016 | 730 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2020 | 2566 | 0.020 |
Why?
|
Cell Hypoxia | 1 | 2013 | 675 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2017 | 1461 | 0.020 |
Why?
|
Regression Analysis | 1 | 2020 | 6459 | 0.020 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2012 | 494 | 0.020 |
Why?
|
Reimbursement Mechanisms | 1 | 2016 | 670 | 0.020 |
Why?
|
Cell Line, Tumor | 3 | 2013 | 16690 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2002 | 10943 | 0.020 |
Why?
|
Radiography, Abdominal | 1 | 2012 | 537 | 0.020 |
Why?
|
Flavonoids | 1 | 2012 | 443 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2019 | 2850 | 0.020 |
Why?
|
Colectomy | 1 | 2014 | 680 | 0.020 |
Why?
|
Morpholines | 1 | 2012 | 571 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2020 | 8642 | 0.020 |
Why?
|
Gene Frequency | 1 | 2015 | 3587 | 0.020 |
Why?
|
Pelvis | 1 | 2012 | 730 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2017 | 1888 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 2016 | 4740 | 0.020 |
Why?
|
Promoter Regions, Genetic | 2 | 2012 | 5867 | 0.020 |
Why?
|
Research | 1 | 2016 | 1999 | 0.020 |
Why?
|
Survival Analysis | 1 | 2020 | 10252 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2016 | 1889 | 0.020 |
Why?
|
Primary Health Care | 1 | 2023 | 4557 | 0.020 |
Why?
|
Cholesterol | 1 | 2016 | 2919 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2023 | 9955 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2018 | 3084 | 0.020 |
Why?
|
Mice | 3 | 2020 | 81201 | 0.020 |
Why?
|
Abdominal Pain | 1 | 2012 | 1064 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2020 | 5856 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2013 | 3554 | 0.020 |
Why?
|
Cohort Studies | 2 | 2020 | 40559 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2020 | 14561 | 0.020 |
Why?
|
Adolescent | 3 | 2020 | 85779 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2013 | 3921 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2020 | 15078 | 0.020 |
Why?
|
Computer Simulation | 1 | 2018 | 6194 | 0.020 |
Why?
|
rho-Associated Kinases | 1 | 2006 | 279 | 0.020 |
Why?
|
Down-Regulation | 1 | 2012 | 3001 | 0.020 |
Why?
|
Liver | 1 | 2020 | 7475 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2016 | 3595 | 0.010 |
Why?
|
Boston | 1 | 2017 | 9312 | 0.010 |
Why?
|
Apoptosis | 1 | 2020 | 9724 | 0.010 |
Why?
|
Referral and Consultation | 1 | 2016 | 3531 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2020 | 63107 | 0.010 |
Why?
|
Cytokines | 1 | 2017 | 7323 | 0.010 |
Why?
|
Hydrogen Peroxide | 1 | 2005 | 730 | 0.010 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2005 | 627 | 0.010 |
Why?
|
Logistic Models | 1 | 2016 | 13409 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2012 | 3799 | 0.010 |
Why?
|
Research Design | 1 | 2017 | 5984 | 0.010 |
Why?
|
Weight Loss | 1 | 2012 | 2625 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2013 | 11366 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2020 | 77460 | 0.010 |
Why?
|
Phenotype | 1 | 2016 | 16367 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2012 | 7721 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2012 | 12961 | 0.010 |
Why?
|
Up-Regulation | 1 | 2005 | 4222 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2012 | 10483 | 0.010 |
Why?
|
Time Factors | 1 | 2017 | 40075 | 0.010 |
Why?
|
Base Sequence | 1 | 2006 | 12797 | 0.010 |
Why?
|
Oxygen | 1 | 2005 | 4189 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2006 | 18111 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2014 | 15297 | 0.010 |
Why?
|
United States | 1 | 2019 | 69872 | 0.010 |
Why?
|
Models, Biological | 1 | 2006 | 9584 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2012 | 20130 | 0.010 |
Why?
|